Adicet Bio Inc
NASDAQ:ACET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Daqo New Energy Corp
NYSE:DQ
|
CN |
|
T
|
Tern Properties Co Ltd
HKEX:277
|
HK |
|
Maider Medical Industry Equipment Co Ltd
SSE:688310
|
CN |
|
S
|
Sekisui Jushi Corp
TSE:4212
|
JP |
|
Airtac International Group
TWSE:1590
|
CN |
|
Parshva Enterprises Ltd
BSE:542694
|
IN |
During the last 3 months Adicet Bio Inc insiders have not bought any shares, and sold 396k USD worth of shares. The stock price has increased by 2% over this period (open performance analysis).
The last transaction was made on
Apr 8, 2026
by
Orbimed Advisors Llc
, who
sold
204.6k USD
worth of 
ACET shares.
During the last 3 months Adicet Bio Inc insiders have not bought any shares, and sold 396k USD worth of shares. The stock price has increased by 2% over this period (open performance analysis).
The last transaction was made on
Apr 8, 2026
by
Orbimed Advisors Llc
, who
sold
204.6k USD
worth of ACET shares.
Adicet Bio Inc
Glance View
Adicet Bio, Inc. is a biotechnology company, which engages in the design and development of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. The company is headquartered in Boston, Massachusetts and currently employs 86 full-time employees. The company went IPO on 2018-01-26. The company is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CAR) and T cell receptor-like antibodies (TCRL), to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response and improve persistence for durable activity in patients. Its lead product candidate, ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is under Phase I study for the treatment of Non-Hodgkin's Lymphoma. Its pipeline also includes ADI-002, an allogeneic gamma delta CAR-T cell therapy expressing a GPC3-targeted CAR and a cell intrinsic soluble form of interluiken-15, for the treatment of solid tumors. In addition, it is engaged in discovery and preclinical stage activities of its pipeline of product candidates for both hematological malignancies and solid tumors.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
